DPRD Abstract Submissions

Please complete this form to submit a plenary.

Please complete this form to submit an abstract.

The categories for abstract submission are:

Morning Plenary Lectures:

To showcase the work of Department members who are conducting exemplary research, we will select the top four papers published over the last year for presentation as Plenary Lectures. We encourage ALL Department members to submit what they consider to be their most significant research publication from March 1, 2020 to February 28, 2021 for consideration.

The plenary submission deadline is March 19, 2021

Afternoon Oral & Poster Presentations:

Please submit research abstracts to be considered for oral and/or poster presentations. Oral presentation sessions will be organized into relevant themes and chaired by our plenary lecturers. Poster slots will be available to showcase the high-quality and varied research being conducted in our department. Awards for best oral and poster presentations will be presented for students, residents, post-doctoral clinical or research fellows, and early career investigators within 5 years of starting an independent research program.

The abstract submission deadline is March 29, 2021


  1. On a multi-authored paper, the presenting person should be the first author.
  2. An individual cannot be a first author on more than one oral or more than one poster presentation. Individuals can be a co-author for more than one oral or poster presentations.
  3. Prepare a brief title, clearly indicating the nature of the investigation. Provide authors’ names and major institutional affiliation(s) ONLY. DO NOT INCLUDE degrees, titles, institutional appointments, street addresses and postal codes. DO NOT mention support of work by a research grant.
  4. Single-space all typing. Abstracts submitted should not be longer than 250 words.
  5. Organize the body of the abstract as follows and include these four headings:
    1. Purpose
    2. Methods
    3. Results
    4. Conclusions/Implications
  6. The use of standard abbreviations is required. Use numerals to indicate numbers, except when beginning a sentence.
  7. Non-proprietary (generic) names are required the first time a drug is mentioned, written in small letters. Proprietary names are always capitalized, e.g. acetazolamide (Diamox).
  8. Abstracts submitted with errors, misspellings, poor hyphenations, skipped lines, incorrect abbreviations, exceeding the allowed word limit, or not conforming to the prescribed guidelines may be REJECTED.
  9. The Research Day Committee reserves the right to make decisions about which submissions will be accepted.

Queries may be directed to the Department of Psychiatry.